A Risk Stratification Model for Low Stage Uterine leiomyosarcoma episode artwork

EPISODE · Jul 7, 2022 · 17 MIN

A Risk Stratification Model for Low Stage Uterine leiomyosarcoma

from Springer Nature · host Springer Nature

Uterine leiomyosarcoma is the most common uterine mesenchymal malignancy. The majority present at stage I with variable clinical outcome. In this episode of ModPath Chat, Dr. David Chapel discusses his recently published multi-institutional study proposing a novel risk stratification model (shown below) for low stage uterine leiomyosarcoma. Risk score = (coagulative necrosis)(1) + (mitoses > 25 per 2.4mm2)(2) + (atypical mitoses)(2) + (lymphovascular invasion)(3) + (serosal abutment)(5)

Episode metadata supplied by the publisher feed · Published Jul 7, 2022

Embed this episode

NOW PLAYING

A Risk Stratification Model for Low Stage Uterine leiomyosarcoma

0:00 17:21

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Springer Nature?

This episode is 17 minutes long.

When was this Springer Nature episode published?

This episode was published on July 7, 2022.

Can I download this Springer Nature episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!